Brannelly Paul

Executive Vice President & CFO at COLL; VP Finance, Treasurer at Sirtris Pharmaceuticals, Inc.

Sold, on record
$444k
Dollars the filings state
Form 4 sales
3
Latest Jun 21, 2018
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Sirtris Pharmaceuticals, Inc.Unusual
    Jan 24, 2008 2008

    Sold 6,548 shares at $12.92 ($85k)

    Brannelly Paul, VP Finance, Treasurer

    Sold 26.1% of holdings ($324k position)18,547 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Sirtris Pharmaceuticals, Inc.Unusual
    Feb 6, 2008 +13 days

    Sold 6,547 shares at $12.29 ($80k)

    Brannelly Paul, VP Finance, Treasurer

    Sold 35.3% of holdings ($228k position)12,000 shares leftFiling

  3. 3 Form 4 sale COLLPlan not stated
    Jun 21, 2018 +3788 days

    Sold 10,000 shares at $27.92 ($279k)

    Brannelly Paul, Executive Vice President & CFO

    Sold 7.5% of holdings ($3.7M position)123,436 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Brannelly Paul
Source
Jun 21, 2018Jun 22, 2018COLLExecutive Vice President & CFOForm 4 sale10,000$279k7.5%Plan not statedSEC
Feb 6, 2008Feb 8, 2008Sirtris Pharmaceuticals, Inc.VP Finance, TreasurerForm 4 sale6,547$80k35.3%UnusualSEC
Jan 24, 2008Jan 28, 2008Sirtris Pharmaceuticals, Inc.VP Finance, TreasurerForm 4 sale6,548$85k26.1%UnusualSEC